|
|
|
|
Neuehealth Inc (NYSE: NEUE) |
|
Price: $7.4000
$0.05 
0.680%
|
| Day's High:
| $7.4
| Week Perf:
| -0.67 %
|
| Day's Low: |
$ 7.27 |
30 Day Perf: |
93.72 % |
| Volume (M): |
40 |
52 Wk High: |
$ 7.64 |
| Volume (M$): |
$ 292 |
52 Wk Avg: |
$5.65 |
| Open: |
$7.30 |
52 Wk Low: |
$3.79 |
|
|
| Market Capitalization (Millions $) |
61 |
| Shares
Outstanding (Millions) |
8 |
| Employees |
- |
| Revenues (TTM) (Millions $) |
704 |
| Net Income (TTM) (Millions $) |
-102 |
| Cash Flow (TTM) (Millions $) |
-497 |
| Capital Exp. (TTM) (Millions $) |
2 |
Neuehealth Inc
Company Address: 9250 NW 36th St Doral 33178 FL
Company Phone Number: 238-1321 Stock Exchange / Ticker: NYSE NEUE
|
|
|
|
|
|
|
| Stock Performances by Major Competitors |
|
|
|
| Business Update
Published Mon, Jun 24 2024 11:47 AM UTC
In a bid to strengthen its position in the rapidly evolving healthcare industry, NeueHealth, Inc. has recently announced securing a term loan facility of up to $150 million with Hercules Capital, Inc. This landmark financing opportunity presents NeueHealth with a unique opportunity to fully leverage its differentiated care model and cement its position as a leader in the shi...
|
| Business Update
Published Tue, Jun 18 2024 9:47 PM UTC
NeueHealth Faces NYSE Non-Compliance Regarding Market Capitalization RequirementsDORAL, Fla. In a recent press release, NeueHealth, Inc. (NeueHealth) (NYSE: NEUE), a value-driven healthcare company, announced that it received a written notice from the New York Stock Exchange (NYSE) on June 12, 2024. This notice indicated that the company no longer meets the continued listi...
|
| Neuehealth Inc
In a surprising turn of events, NeueHealth Inc recently announced disappointing financial results for its most recent fiscal period. With a decline in revenue of -67.595% to $245.10 million and a significant increase in net loss per share to $-3.53, it is clear that the company faced significant challenges during this period. However, despite these setbacks, NeueHealth remains optimistic and focused on its long-term goals.
The previous fiscal period saw a tremendous decline in net loss per share, from $0.00 to $-3.53. This sequential decrease highlights the challenges NeueHealth faced and the need for strategic planning to overcome these obstacles. Additionally, the company reported a net loss of $-4.177 million, a significant improvement compared to the deficit of $-169.461 million in the corresponding period the previous year.
|
| Neuehealth Inc
NeueHealth, Inc. has recently released its financial results for the fourth quarter and full year ended December 31, 2023. The company is a value-driven healthcare organization and is listed on the New York Stock Exchange under the ticker symbol NEUE. Despite challenges in the past, NeueHealth has made significant progress and achieved various milestones in the past year.
One of the major highlights for NeueHealth is the completion of the sale of its California Medicare Advantage business. This strategic move allowed the company to fully focus on its core operations - care delivery and provider enablement business. By redirecting their attention towards these areas, NeueHealth believes that it can deliver the greatest impact within the healthcare industry.
|
| Per Share |
Current |
| Earnings (TTM) |
-20.69 $ |
| Revenues (TTM) |
85.01 $
|
| Cash Flow (TTM) |
- |
| Cash |
14.33 $
|
| Book Value |
-
|
| Dividend (TTM) |
0 $ |
|
|
| Per Share |
|
| Earnings (TTM) |
-20.69 $
|
| Revenues (TTM) |
85.01 $ |
| Cash Flow (TTM) |
- |
| Cash |
14.33 $
|
| Book Value |
- |
| Dividend (TTM) |
0 $ |
|
|
| |
| Total unaffiliated revenue |
|
 100 % |
of total Revenue |
| Capitated revenue |
|
30.62 % |
of total Revenue |
| Service revenue |
|
5.01 % |
of total Revenue |
| Corporate Eliminations |
|
-1.28 % |
of total Revenue |
| Corporate Eliminations Total unaffiliated revenue |
|
-0 % |
of total Revenue |
| Corporate Eliminations Affiliated revenue |
|
-1.27 % |
of total Revenue |
| NeueCare |
|
36 % |
of total Revenue |
| NeueCare Total unaffiliated revenue |
|
34.73 % |
of total Revenue |
| NeueCare Affiliated revenue |
|
1.27 % |
of total Revenue |
| NeueCare Capitated revenue |
|
30.62 % |
of total Revenue |
| NeueCare Service revenue |
|
3.91 % |
of total Revenue |
| NeueSolutions |
|
65.27 % |
of total Revenue |
| NeueSolutions Total unaffiliated revenue |
|
65.27 % |
of total Revenue |
| NeueSolutions Service revenue |
|
1.1 % |
of total Revenue |
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
